TotalMarketCap

Tg Therapeutics

TGTXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$8.875 B

$57.98 -5.92%

Close of 6 Nov 2026

As of 6 Nov 2026, Tg Therapeutics (TGTX) has a market capitalization of $8.87B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$616.3M

#1783 by revenue

Earnings

$447.2M

#657 by earnings

Shares outstanding

153,069,053

Latest filing cover page

P/E ratio

19.8

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #33Madrigal PharmaceuticalsMDGL$9.30B
  2. #34Spyre TherapeuticsSYRE$9.21B
  3. #35Tg TherapeuticsTGTX$8.87B
  4. #36Protagonist TherapeuticsPTGX$8.76B
  5. #37Arrowhead PharmaceuticalsARWR$8.11B

What if Tg Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$184,471.47

Per share 3,182× higher

Bitcoin $1.53T

$9,981.43

Per share 172× higher

Apple $5.02T

$32,768.10

Per share 565× higher

Or at a round number

$20.0B$50.0B$100.0B$200.0B

Where these numbers come from

Share counts and financials for Tg Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.